Natural Killer Cells Complexed With a Bispecific Antibody May Provide New Treatment Option for Patients With Advanced Lymphoma
NEW ORLEANS – Natural killer (NK) cells derived from cord blood that were activated and complexed with a CD30/CD16A...
NEW ORLEANS – Natural killer (NK) cells derived from cord blood that were activated and complexed with a CD30/CD16A...
Two-year follow up of the CodeBreaK 100 clinical trial demonstrated prolonged tumor responses and a favorable safety profile NEW...
NEW ORLEANS – Preliminary data from an artificial intelligence model could potentially predict side effects resulting from new combination...
NEW ORLEANS – An artificial intelligence (AI) model trained using sequential health information derived from electronic health records identified...
Five new members elected to the Board of Directors and four new members elected to the Nominating Committee PHILADELPHIA...
Awardees to be recognized at the AACR Annual Meeting 2022 in New Orleans PHILADELPHIA — The American Association for...
PHILADELPHIA – The American Association for Cancer Research (AACR) will honor Ira Mellman, PhD, Fellow of the AACR Academy,...
PHILADELPHIA – Victoria’s Secret, Pelotonia, and the American Association for Cancer Research (AACR) today announced the recipients of The...
PHILADELPHIA – Today, the AACR issued the following statement regarding President Biden’s fiscal year (FY) 2023 budget proposal: “The...
PHILADELPHIA – The American Association for Cancer Research (AACR) will recognize Levi A. Garraway, MD, PhD, Fellow of the...